Orlando Pompei Fernández, Paula García Escudero, Marta González Fernández, Claudia Stoye, César Antonio Egües, Jose Francisco García Llorente, Itziar Calvo Zorrilla, Oihane Ibargüengoitia Barrena, Ana Ruibal-Escribano, Juan Ramón De Dios, Joaquín María Belzunegui Otano, Belén Álvarez Rodríguez, Susana Gil Barato, Elena Garmendia Sánchez, Margarida Vasques Rocha, Edurne Guerrero, Jaime Calvo-Alén
BACKGROUND: Since the first confirmed case of severe acute respiratory syndrome coronavirus 2 in Spain in January 2020, the susceptibility of patients with rheumatic disease has remained unclear. In this report, we will describe the main features of coronavirus disease 2019 (COVID-19) that occurred in rheumatic patients with inflammatory disorders and try to identify features associated with severe disease. METHODS: We included all rheumatic patients with immune-mediated diseases followed at 6 centers belonging to the public healthcare system in the Basque Country (Spain) and diagnosed with COVID-19 from March 1, 2020, to May 31, 2020...
October 2023: European Journal of Rheumatology